Literature DB >> 6272275

Interconverting mu and delta forms of the opiate receptor in rat striatal patches.

W D Bowen, S Gentleman, M Herkenham, C B Pert.   

Abstract

The binding of a radiolabeled "mu receptor" prototype opiate, dihydromorphine (H2morphine), and the binding of a "delta receptor" prototype, [D-Ala2,D-Leu5]enkephalin (D-Enk), to slide-mounted rat caudate slices were simultaneously compared quantitatively and visualized by autoradiography. Generally, D-Enk bound to opiate receptors distributed evenly throughout the entire striatum (type 2 pattern), whereas H2morphine labeled discrete islands or patches of receptors (type 1 pattern). In the presence of Mn2+ (3 mM) or other divalent cations, however, Na+ and GTP at 25 degrees C caused an increase in D-Enk binding at the expense of H2morphine binding at striatal opiate receptor patches. Thus, these conditions shifted D-Enk binding from an even pattern to one that included both an even and patchy distribution. These incubation conditions not only promoted D-Enk binding to striatal patches but also enabled the opiate receptor to regulate adenylate cyclase with the same (P less than 0.01) ligand selectivity pattern as that obtained by the displacement of D-Enk binding. The relative affinity of opiate receptors in striatal patches for opiate peptides, naloxone, and morphine appears to be a function of incubation conditions and coupling to adenylate cyclase and is not indicative of distinctly different opiate receptors. We postulate a three-state allosteric model consisting of mu agonist-, mu antagonists-, and adenylate cyclase-coupled delta-agonist-preferring states, whose equilibrium may be regulated by a sulfhydryl group mechanism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272275      PMCID: PMC320261          DOI: 10.1073/pnas.78.8.4818

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Correlation of opiate receptor affinity with analgetic effects of meperidine homologues.

Authors:  C B Pert; S H Snyder
Journal:  J Med Chem       Date:  1976-10       Impact factor: 7.446

2.  Discrimination by temperature of opiate agonist and antagonist receptor binding.

Authors:  I Creese; G W Pasternak; C B Pert; S H Snyder
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

3.  Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions.

Authors:  E J Simon; J Groth
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

4.  The mobile receptor hypothesis and "cooperativity" of hormone binding. Application to insulin.

Authors:  S Jacobs; P Cuatrecasas
Journal:  Biochim Biophys Acta       Date:  1976-05-21

5.  Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor.

Authors:  L T Williams; R J Lefkowitz
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

6.  Homologous N-alkylnorketobemidones. Correlation of receptor binding with analgesic potency.

Authors:  R S Wilson; M E Rogers; C B Pert; S H Snyder
Journal:  J Med Chem       Date:  1975-03       Impact factor: 7.446

7.  Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides.

Authors:  A J Blume
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

8.  An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and time course of degeneration.

Authors:  D A Matthews; C Cotman; G Lynch
Journal:  Brain Res       Date:  1976-10-08       Impact factor: 3.252

9.  Guanyl nucleotide influences on 3H-ligand binding to alpha-noradrenergic receptors in calf brain membranes.

Authors:  D C U'Prichard; S H Snyder
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

10.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

View more
  27 in total

1.  Synaptic localization of kappa opioid receptors in guinea pig neostriatum.

Authors:  C Jomary; J E Gairin; A Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

2.  Opiate receptors and the endorphin-mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced mu-subtype to delta-subtype changes.

Authors:  R Mosqueda-Garcia; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 3.  Development of delta opioid peptides as nonaddicting analgesics.

Authors:  R S Rapaka; F Porreca
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

Review 4.  Opioids and exercise. An update.

Authors:  G A Sforzo
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

5.  Opioid peptides.

Authors:  J W Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

6.  Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine.

Authors:  R Quirion; C Pilapil; J Magnan
Journal:  Cell Mol Neurobiol       Date:  1987-09       Impact factor: 5.046

Review 7.  The next frontier in the molecular biology of the opioid system. The opioid receptors.

Authors:  O Civelli; C Machida; J Bunzow; P Albert; E Hanneman; J Salon; J Bidlack; D Grandy
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

8.  Construction of a yeast actin gene intron deletion mutant that is defective in splicing and leads to the accumulation of precursor RNA in transformed yeast cells.

Authors:  D Gallwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  Multiple opioid receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo.

Authors:  R D'Amato; J W Holaday
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 10.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.